首页> 外文会议>Cell culture engineering conference >MODULATION OF HALF ANTIBODY AND AGGREGATE FORMATION IN A CHO CELL LINE EXPRESSING A BISPECIFIC ANTIBODY
【24h】

MODULATION OF HALF ANTIBODY AND AGGREGATE FORMATION IN A CHO CELL LINE EXPRESSING A BISPECIFIC ANTIBODY

机译:在表达双特异性抗体的CHO细胞系中的半抗体和聚集体形成的调节

获取原文

摘要

Therapeutic bispecific antibodies are formed by assembly of multichain polypeptides. In general, a bispecific antibody has two different light chains and two heavy chains that fold and correctly pair via a diversity of engineered interchain interactions (e.g., orthogonal interface, domain crossover, charged mutations, sterically complementary mutations [1-3]). As a consequence of these complex mechanisms that mediate chain assembly, product-related impurities (e.g., half antibodies, homodimers, mispaired light chain species) can be prevalent when expressing bispecific antibodies in cell culture, requiring its removal during subsequent purification. In this study, we investigated the modulation of impurity levels in a stable CHO cell line X expressing a bispecific antibody formed by light chains LC1 and LC2 and heavy chains HC1 and HC2. In particular, this cell line responded to cell culture temperature by decreasing half antibody formation from -14% to less than 3% when temperature changed from 36°C to 32.5°C. However, the decrease in half antibody also correlated with increased protein aggregates from -4% to -10%. We established that half antibody and aggregate formation correlated to intracellular events and not to extracellular degradation mechanism (studies included Western blots of cell lysates and extended supernatant incubation). Analytical characterization showed that protein A-purified pools from cell line X cultured at lower temperatures were enriched in LC1-contaning species, whereas pools from cultures at 36°C were enriched in LC2-containing species. When comparing the LC1 to LC2 ratio in antibodies secreted by cell line X to the ratio in another different 30 cell lines expressing the same bispecific antibody, it revealed a pattern with half antibody formation only present in ratios lower than one, and with enhanced aggregation in ratios larger than one. These results suggested the imbalance of expressed light chains led to one of the two main impurities being preferentially formed. Further studies for cell line X showed that cell culture temperature also modulated mRNA levels of the four expressed chains, which possibly led to misassembled species that contributed to either increased half antibody levels at 36°C (enriched with LC2-containing species), or increased aggregate formation at 32.5X (enriched with LC1-containing species). Overall, we identified culture conditions that could alter the overall process yield by adjusting impurity amounts and types and consequently, the impurity separation in subsequent purification steps such as cation exchange chromatography.
机译:治疗性的双特异性抗体是通过多链多肽的装配来形成。一般地,双特异性抗体具有两个不同的轻链和两条重链折叠和通过的多样性正确配对设计的链间相互作用(例如,正交接口,域交叉,带电突变,位互补的突变[1-3])。由于这些复杂的机制的结果,其介导链组件,与产品相关的杂质(例如,半抗体,同型二聚体,错配的轻链种)可以表达在细胞培养物的双特异性抗体时,随后的纯化过程中,需要将其移除是普遍的。在这项研究中,我们调查了杂质水平的调节以稳定的CHO细胞系X表达由轻链LC1和LC2链和重链HC1和HC2形成的双特异性抗体。特别地,该细胞系由当温度从36℃变更为32.5从-14%半抗体形成减少到小于3%℃的回应细胞培养温度。然而,在半抗体的减少也具有提高的蛋白质聚集体相关从-4%至-10%。我们建立了半抗体和聚集形成相关的细胞内事件,而不是细胞外降解机理(研究包括细胞裂解物的Western印迹和扩展上清孵育)。分析表征表明,从蛋白质在较低温度下培养的细胞系X A纯化的在池LC1-contaning物种中富集,而在36从培养池℃下在含有LC2物种中富集。当由细胞生产线X中表达相同特异性抗体的另一不同30个细胞系分泌到比抗体比较LC1到LC2比,它揭示了与半抗体形成只存在于比的图案低于1,用在增强的聚合比率大于一。这些结果表明导致被优先形成的两个主要杂质之一表达轻链的不平衡。对于细胞系X进一步的研究表明,细胞培养物的温度也被调节的四个表示链,其可能导致错误装配物种促成任一的mRNA水平在36℃下增加的半衰期的抗体水平(用含LC2物种富集),或增加的聚集体形成在32.5X(用含有LC1-物种富集)。总体而言,我们确定了可以改变通过调整杂质的量和类型,因此整体工艺产率的培养条件,在随后的纯化的杂质分离步骤如阳离子交换色谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号